Overview

A Study For Pregabalin In Patients With Fibromyalgia

Status:
Completed
Trial end date:
2016-10-31
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the efficacy and tolerability of pregabalin compared with placebo for management of fibromyalgia in adults.
Phase:
Phase 3
Details
Lead Sponsor:
Pfizer
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Treatments:
Pregabalin